Literature DB >> 21432401

Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts.

Q Zhang1, Y Mo, J Lou, X Zhu, Z Chen, L He, H Zhong.   

Abstract

Platelet-activation factor (PAF), one of the potent proinflammatory mediators, is produced from a large range of cells, including polymorphonuclear neutrophils, monocytes, and natural killer cells. To study the role of PAF in the pathogenesis of silicosis, we determined the PAF in silicotic patients and in healthy persons. The results showed that the concentration of PAF in the plasma of silicotic patients was significantly higher than that of healthy persons. Ourin vitro experimental results showed that the total numbers of fibroblasts were markedly raised with added PAF from 0 to 1 μ g/ml. Adding 1 μ g/ml PAF significantly increased the total numbers of fibroblasts after culture for 48, 72, 96 hrs. Therefore, we suggest that PAF be possibly involved in the pathogenesis of silicosis. However, the mechanism remains to be further elucidated.

Entities:  

Keywords:  Fibroblasts; Platelet activating factor (PAF); Silicosis

Year:  2001        PMID: 21432401      PMCID: PMC2723277          DOI: 10.1007/BF02918288

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  22 in total

Review 1.  Interactions between airway epithelium and mediators of inflammation.

Authors:  L A Cohn; K B Adler
Journal:  Exp Lung Res       Date:  1992 May-Jun       Impact factor: 2.459

Review 2.  An update on PAF.

Authors:  D A Spencer
Journal:  Clin Exp Allergy       Date:  1992-05       Impact factor: 5.018

3.  Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

Authors:  T W Evans; K F Chung; D F Rogers; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1987-08

4.  Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.

Authors:  D D Morris; J N Moore
Journal:  Circ Shock       Date:  1989-06

5.  Mast cells are essential for the full development of silica-induced pulmonary inflammation: a study with mast cell-deficient mice.

Authors:  N Suzuki; T Horiuchi; K Ohta; M Yamaguchi; T Ueda; H Takizawa; K Hirai; J Shiga; K Ito; T Miyamoto
Journal:  Am J Respir Cell Mol Biol       Date:  1993-11       Impact factor: 6.914

6.  The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.

Authors:  A Floch; L Tahraoui; P Sedivy; I Cavero
Journal:  J Pharmacol Exp Ther       Date:  1991-08       Impact factor: 4.030

7.  Atherosclerosis, cell motility, calcium, and calcium-channel blockers.

Authors:  L H Block; F R Bühler
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes.

Authors:  R N Pinckard; E M Jackson; C Hoppens; S T Weintraub; J C Ludwig; L M McManus; G E Mott
Journal:  Biochem Biophys Res Commun       Date:  1984-07-18       Impact factor: 3.575

Review 9.  Platelet-activating factor (PAF): an introduction.

Authors:  S Nojima
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 10.  Minerals, fibrosis, and the lung.

Authors:  A G Heppleston
Journal:  Environ Health Perspect       Date:  1991-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.